1 / 9

Avelient’s “Web and You”

Avelient’s “Web and You”. http://webandyou.avelient.com. Having the Conversation with Pharmaceuticals and Biotechs Mariano Di Fabio. What we will cover. What are we talking about when we refer to “Social Media?” How is the industry involved in Social Media today?

linh
Download Presentation

Avelient’s “Web and You”

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Avelient’s “Web and You” • http://webandyou.avelient.com

  2. Having the Conversation with Pharmaceuticals and BiotechsMariano Di Fabio

  3. What we will cover • What are we talking about when we refer to “Social Media?” • How is the industry involved in Social Media today? • What does the FDA say about Social Media? • How can the industry get involved?

  4. 1. What is “Social Media?” • Social Media is Web 2.0 • Simplicity and being social • Social Media is interactive • Social Media is a dialog

  5. 2. How is the industry social? • Best Example: J&J BTW • Run by Marc Monseau, blog & Twitter • Merck: Gardasil on Facebook • Bayer Group: Bayer Aspirin on Facebook • AstraZeneca: Arimidex Community site • Novartis on Twitter

  6. 3. FDA input • Initial response: Social media okay for message delivery • Documenting recommendations for internet and social media usage for fall release • Main concern: direct-to-consumer information is accurate and complete

  7. 4. Industry Involvement • Blogging: Adopt J&J’s model for blogging and providing community value • Twitter: Could follow the Novartis model, but difficult to adapt • Facebook: Follow Merck or Bayer model • Unique social networking site targeted at Life Sciences professional.

  8. Further Reading • http://www.washingtonpost.com/wp-dyn/content/article/2009/06/12/AR2009061203230.html • http://www.scottmonty.com/2007/10/pharma-sponsored-social-network_15.html • http://www.eyeonfda.com/eye_on_fda/2007/09/social-media-an.html • http://pharmamkting.blogspot.com/2009/01/real-reason-why-pharma-hates-social.html • Additional reading available as links within articles.

  9. Questions/ Discussion

More Related